Treatment outcomes with sorafenib in advanced hepatocellular carcinoma: A single-center retrospective study

被引：0
|
作者：
Prejac, J. [1 ]
Tomek, D. [1 ]
Kekez, D. [1 ]
Majerovic, M. [2 ]
Plestina, S. [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Dept Oncol, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-285
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [31] Hepatocellular Carcinoma Epigenetic Patterns Correspond to Differences in Ethnoracial Status and Treatment Response in a Single-Center Retrospective Study
    Vijayakumar, Vishwaarth
    Gaba, Ron C.
    Huang, Yu-Hui
    Davis, Isaiah
    Roman, Ricardo
    Guzman, Grace
    Lokken, R. Peter
    Schachtschneider, Kyle M.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2024, 35 (05) : 731 - 743.e36
  • [32] Treatment outcomes of small cell carcinoma of the prostate - A single-center study
    Spiess, Philippe E.
    Pettaway, Curtis A.
    Vakar-Lopez, Funda
    Kassouf, Wassirn
    Wang, Xuemei
    Busby, Joseph E.
    Do, Kirn-Anh
    Davuluri, Rajayogesh
    Tannir, Nizar M.
    CANCER, 2007, 110 (08) : 1729 - 1737
  • [33] Camrelizumab combined with sorafenib versus sorafenib alone in patients with advanced hepatocellular carcinoma: A retrospective study
    Liu, Q.
    Li, J.
    You, N.
    Wu, K.
    Wang, Z.
    Zhu, Y.
    Wang, L.
    Zheng, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S131 - S132
  • [34] The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)
    Wong, Hilda
    Tang, Yuen Fong
    Yao, Tzy-Jyun
    Chiu, Joanne
    Leung, Roland
    Chan, Pierre
    Cheung, Tan To
    Chan, Albert C.
    Pang, Roberta W.
    Poon, Ronnie
    Fan, Sheung-Tat
    Yau, Thomas
    ONCOLOGIST, 2011, 16 (12): : 1721 - 1728
  • [35] Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: A retrospective, single-institution study
    Lee, S.
    Yoon, S.
    Shin, S.
    Choi, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [36] Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study
    Lee, Soohyeon
    Yoon, Sang Hyun
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Choi, Hye Jin
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1150 - 1157
  • [37] Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience
    Endo, Masatsugu
    Nishikawa, Hiroki
    Kita, Ryuichi
    Kimura, Toru
    Ohara, Yoshiaki
    Sakamoto, Azusa
    Saito, Sumio
    Nishijima, Norihiro
    Nasu, Akihiro
    Komekado, Hideyuki
    Osaki, Yukio
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 515 - 522
  • [38] Oxaliplatin/5-fluorouracil in advanced hepatocellular carcinoma: case report and single-center retrospective review
    Goldstein, Robert
    Yu, Dominic
    Gillmore, Roopinder
    Thirlwell, Christina
    O'Donoghue, Pam
    Mayer, Astrid
    Meyer, Tim
    FUTURE ONCOLOGY, 2014, 10 (13) : 2007 - 2014
  • [39] Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study
    Soohyeon Lee
    Sang Hyun Yoon
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Kwang-Hyub Han
    Hye Jin Choi
    Investigational New Drugs, 2012, 30 : 1150 - 1157
  • [40] Treatment of advanced hepatocellular carcinoma: beyond sorafenib
    Meyer, Tim
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (04): : 218 - 220
12345